Medicare Enrolled
Dr. Thomas Feeney, M.D.
Cardiovascular Disease · Daly City, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Feeney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feeney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Feeney
Dr. Thomas Feeney is a cardiovascular disease specialist in Daly City, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Feeney performed 2,987 Medicare services across 1,815 unique beneficiaries.
Between the years covered by Open Payments, Dr. Feeney received a total of $120,813 from 71 pharmaceutical and/or device companies across 1095 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feeney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 36% volume in CA
$120,813 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,987
Medicare services
Top 36% in CA for cardiovascular disease
1,815
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~149 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,499 | $7 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
283 | $69 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $78 | $170 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $112 | $220 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
203 | $59 | $140 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
148 | $43 | $166 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
91 | $106 | $300 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
74 | $86 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
52 | $13 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
45 | $102 | $230 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $133 | $375 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
37 | $410 | $593 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
37 | $60 | $193 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
9.9% medium
83.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$120,813
Total received (2018-2024)
Avg $17,259/year across 7 years
Top 6% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,095
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$104,243 (86.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,569 (13.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,360
2023
$17,329
2022
$27,900
2021
$28,782
2020
$7,347
2019
$19,167
2018
$6,928
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,831
Janssen Pharmaceuticals, Inc
$3,763
AstraZeneca Pharmaceuticals LP
$3,316
Boston Scientific Corporation
$286
Merck Sharp & Dohme LLC
$253
Amgen Inc.
$188
ABBVIE INC.
$123
Novartis Pharmaceuticals Corporation
$110
E.R. Squibb & Sons, L.L.C.
$109
Neurocrine Biosciences, Inc.
$94
Novo Nordisk Inc
$67
PFIZER INC.
$58
Esperion Therapeutics, Inc.
$53
Chiesi USA, Inc.
$37
Kiniksa Pharmaceuticals International, plc
$32
Edwards Lifesciences Corporation
$25
Dexcom, Inc.
$17
Top 3 companies account for 89.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$57,780
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$31,259
AstraZeneca Pharmaceuticals LP
$17,589
Boston Scientific Corporation
$1,420
Abbott Laboratories
$1,346
Amgen Inc.
$1,184
E.R. Squibb & Sons, L.L.C.
$1,031
Novartis Pharmaceuticals Corporation
$873
Merck Sharp & Dohme LLC
$786
Chiesi USA, Inc.
$744
BOSTON SCIENTIFIC CORPORATION
$650
PFIZER INC.
$579
Novo Nordisk Inc
$564
ARBOR PHARMACEUTICALS, INC.
$476
SANOFI-AVENTIS U.S. LLC
$331
Medtronic Vascular, Inc.
$310
Boehringer Ingelheim Pharmaceuticals, Inc.
$259
Merck Sharp & Dohme Corporation
$203
Amarin Pharma Inc.
$199
Bayer Healthcare Pharmaceuticals Inc.
$195
Arbor Pharmaceuticals, Inc.
$185
ABBVIE INC.
$176
CHIESI USA, INC.
$169
GlaxoSmithKline, LLC.
$151
Esperion Therapeutics, Inc.
$139
Lundbeck LLC
$131
Mylan Specialty L.P.
$129
Regeneron Healthcare Solutions, Inc.
$128
Biogen, Inc.
$128
Lilly USA, LLC
$113
Astellas Pharma US Inc
$109
Neurocrine Biosciences, Inc.
$94
Philips Electronics North America Corporation
$87
West-Ward Pharmaceuticals
$81
Teva Pharmaceuticals USA, Inc.
$79
MEDICOMP INC
$65
Sunovion Pharmaceuticals Inc.
$63
Terumo Medical Corporation
$58
Hikma Pharmaceuticals USA
$58
Biohaven Pharmaceutical Holding Company Ltd.
$52
ACADIA Pharmaceuticals Inc
$48
Nestle HealthCare Nutrition Inc.
$43
Dexcom, Inc.
$41
Bardy Diagnostics, Inc.
$40
SCILEX PHARMACEUTICALS INC.
$38
Melinta Therapeutics, Inc.
$38
ASSERTIO THERAPEUTICS, Inc.
$36
Kiniksa Pharmaceuticals International, plc
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
CathWorks, Inc.
$30
ORGANOGENESIS INC.
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$28
Kiniksa Pharmaceuticals, Ltd.
$27
Alnylam Pharmaceuticals Inc.
$27
Corcept Therapeutics
$26
Medtronic, Inc.
$25
Edwards Lifesciences Corporation
$25
Bayer HealthCare Pharmaceuticals Inc.
$24
Allergan Inc.
$22
Kowa Pharmaceuticals America, Inc.
$22
Scilex Pharmaceuticals Inc.
$22
Lexicon Pharmaceuticals, Inc.
$22
Daiichi Sankyo Inc.
$21
Kestra Medical Technology Services, Inc.
$21
Eisai Inc.
$21
Genentech USA, Inc.
$20
Allergan, Inc.
$18
iRhythm Technologies, Inc.
$18
BioDelivery Sciences International, Inc.
$16
Smith+Nephew, Inc.
$15
Collegium Pharmaceutical, Inc.
$14
Top 3 companies account for 88.3% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · AMBULATORY CARDIAC MONITOR · AMPLATZER AMULET · APTIOM · AVVIGO · AVVIGO Guidance System · Amitiza · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · Azure · BASAGLAR · BELBUCA · BELSOMRA · BRILINTA · BYSTOLIC · Baxdela · CAMZYOS · CARDENE · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · COLLAGENASE SANTYL · COMET · CONFIRM RX · Carnation Ambulatory Monitor · Comet · Confirm Rx · Corlanor · DAKLINZA · Dayvigo · Dexcom G6 Transmitter · EKOSONIC · ELIQUIS · ELUVIA · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EnSite Precision Cardiac Mapping System · Expo · FARXIGA · FFRangio System · FilterWire EZ · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL THERAPIES · GENERAL - STENTS · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GLYXAMBI · General - Stents · Glidesheath · Gralise · IGT D Peripheral · IN.PACT Admiral · INGREZZA · INJECTAFER · INVOKANA · Inpefa · JANUVIA · JARDIANCE · JETSTREAM · JETSTREAM SC · KENGREAL · KENGREAL 50MG/10ML L · KYNMOBI · Kerendia · Korlym · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · MAMBA · MYRBETRIQ · Micra · Mitigare · NEXLETOL · NORTHERA · NUPLAZID · NURTEC ODT · ONPATTRO · OPTICROSS · OptiCross · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Prolia · Puraply · QVAR · Quadra Assura CRT Defibrillator · ROTABLATOR · ROTAPRO · RYBELSUS · Ranger · Repatha · Reveal LINQ · Rybelsus · SKYRIZI · SYMBICORT · SYNERGY · SelectSecure · TELEPATCH CARDIAC MONITOR · TOUJEO · TR Band · TRELEGY ELLIPTA · TRULICITY · Tresiba · Uloric · VERQUVO · VRAYLAR · VYNDAQEL · Vabomere · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · XARELTO · XIFAXAN · XIFAXANIBSD · Xience V coronary stent system · Xofluza · Xtampza ER · Yupelri · ZENPEP · ZIO XT Patch · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
267
Per 100K population
35.8
County median income
$156,000
Nearest hospital
AHMC SETON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Feeney is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Feeney experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Feeney performed 1,499 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Feeney receive payments from pharmaceutical companies?
Yes. Dr. Feeney received a total of $120,813 from 71 companies across 1,095 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feeney's costs compare to other cardiologists in Daly City?
Dr. Feeney's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feeney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Daly City
Browse cardiologists in Daly City ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology